Urinalysis Market by Products (Instruments [Biochemical Urine Analyzers {Automated Biochemical Analyzers and Semi-automated Biochemical Analyzers} and Automated Urine Sediment Analyzers {Microscopic Urine Analyzers and Flow-Cytometric Urine Analyzers}] and Consumables [Dipsticks, Reagents, and Disposables]), Applications (Urinary Tract Infections, Diabetes, Kidney Disease, Hypertension, Liver Disease, and Others), End-users (Hospitals, Clinical Laboratories, Home Healthcare, Research & Academics, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

The global urinalysis market size is expected to expand at a substantial CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the increase in the occurrence of new cases of several diseases each year and wide applications of the diagnostic method for several diseases.
 

Urinalysis refers to the diagnostics analysis of urine. This test is extensively used for the detection and management of a large number of diseases, which are originated from the organs related to excretory system of the patient body. Some of the common diseases that require urinalysis include kidney diseases, diabetes, and urinary tract infection. The initial procedure of urinalysis involves checking the concentration, content, and appearance of urine and the results shown in this procedure will determine the patients’ health status. Performing a urinalysis test on a patient helps to understand the overall health of the patient by monitoring & diagnosing their medical conditions.

According to a survey conducted by World Health Organization (WHO), more than one million of urinalysis tests were conducted in North America alone in 2019. This was due to the rising number of diabetics and obesity patients in the region and the urinalysis procedure was widely adopted for the diagnostic procedures. The urology department of Istanbul National Hospital developed a rapid and simple urine test for the COVID-19 patients for the identification of false positive patients from the real ones. This test is called the Urine Foaming Test (UFT) making a significant rise in the urinalysis market. This test basically involves testing the foam of urine from the patient’s body and identify the coronavirus gene from this sample.

Market Trends, Drivers, Restraints, and Opportunities

• Increasing occurrence of infectious diseases and chronic illness due to the inactive lifestyle and unhealthy eating habits such as extreme consumption of alcohol & smoking are projected to boost the market growth.
• Rapid development of the advanced urinalysis diagnostics and rising growth of the pharmaceutical sector are major factors driving the market expansion in the coming years.
• High maintenance cost for urinalysis testing devices and equipment as they need to be maintained in proper cooling systems and a favorable environment. This is expected to hinder the market growth.
• Lack of adequate healthcare infrastructure especially in the developing regions present a main challenge that can restrict the market expansion in the coming years.
• R&D investment and technological advancement in the development of innovative kinds of dipsticks and measurement devices for parameters such as acidity, protein, sugar, bilirubin, blood, evidence of infection, concentration, and ketones are expected to offer significant opportunities for the market players.             

Scope of the Report

The report on the global urinalysis market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Global Urinalysis Market Segment Insights

Instruments segment is projected to represent a large market share
Based on products, the global urinalysis market is bifurcated into instruments and consumables. The instruments segment is further divided into biochemical urine analyzers and automated urine sediment analyzers. The biochemical urine analyzers segment is sub-divided into automated biochemical analyzers and semi-automated biochemical analyzers. Similarly, the automated urine sediment analyzers segment is sub-segmented into microscopic urine analyzers and flow-cytometric urine analyzers. On the other hand, the consumables segment is further classified into dipsticks, reagents, and disposables. The instruments segment is expected to constitute a major share of the market during the forecast years owing to the development of new technology such as the completely automated urine strip readers along with computerized sediment analyzers.

Urinary tract Infections segment is expected to grow at a significant pace
On the basis of application areas, the market is divided into urinary tract infections (UTIs), diabetes, kidney disease, hypertension, liver disease, and others. The UTIs segment is expected to constitute a major share, accounting for more than 25.8% of the global market during the forecast period owing to the increasing adoption of the diagnosis for UTIs detection and wide process of hospitals inducting equipment for the treatment of the infection.

Clinical Laboratories is anticipated to expand at a substantial pace
Based on end-users, the global urinalysis market is divided into hospitals, clinical laboratories, home healthcare, research & academics, and others. The clinical laboratories segment is anticipated to represent a major share, representing for more than 35% of the market during the forecast period due to the high volumes of procedures and experiments that are taking place in the clinical laboratories. The urine analysis and diagnostics are currently undergoing a key transformation to automation for providing effective diagnostics results from self-testing urinalysis devices.
 

North America is anticipated to dominate the market
On the basis of regions, the market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to expand at an impressive and healthy CAGR during the forecast period owing to the acceleration of research and development activities in various fields of urinalysis diagnostics. Moreover, the presence of key market players and early acceptance of advanced technology for diagnostic devices by key players in this region are acting as major driving factors for the regional market growth.
 

Segments

Segments Covered in the Report
The global urinalysis market has been segmented in terms of

Products

• Instruments
  • Biochemical Urine Analyzers
    • Automated Biochemical Analyzers
    • Semi-automated Biochemical Analyzers
  • Automated Urine Sediment Analyzers
    • Microscopic Urine Analyzers
    • Flow-Cytometric Urine Analyzers
• Consumables
  • Dipsticks
  • Reagents
  • Disposables

Applications

• Urinary Tract Infections
• Diabetes
• Kidney Disease
• Hypertension
• Liver Disease
• Others

End-users

• Hospitals
• Clinical Laboratories
• Home Healthcare
• Research & Academics
• Others

Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Alere Inc.
• ARKRAY Inc.
• Bio-Rad
• Mindray
• Roche Diagnostics
• Siemens Healthcare
• Sysmex

Competitive Landscape

Major players competing in the global urinalysis market are Alere Inc; ARKRAY Inc; Bio-Rad; Mindray; Roche Diagnostics; Siemens Healthcare; and Sysmex. These market players are involved in several business strategies such as mergers, acquisitions partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. They are simultaneously looking to innovate their products portfolio to get a competitive edge in the market. For instance, in April 2020, Roche Diagnostics developed technology called the UriSed mini and the UriSed 2, which were considered to be helping to perform diagnosis of the sample urine from patients at higher speeds and reported the result almost immediately.